Introduction to the iHuPDX model of InnoModels Biotechnology
- Categories:Company news
- Author:InnoModels
- Origin:InnoModels
- Time of issue:2024-08-16 16:12
- Views:
(Summary description)The iHuPDX model of InnoModels Biotechnology is a xenotransplantation technology based on individual patient's tumor cells, aiming to establish a more realistic and individualized cancer model.
Introduction to the iHuPDX model of InnoModels Biotechnology
(Summary description)The iHuPDX model of InnoModels Biotechnology is a xenotransplantation technology based on individual patient's tumor cells, aiming to establish a more realistic and individualized cancer model.
- Categories:Company news
- Author:InnoModels
- Origin:InnoModels
- Time of issue:2024-08-16 16:12
- Views:
The iHuPDX model of InnoModels Biotechnology is a xenotransplantation technology based on individual patient's tumor cells, aiming to establish a more realistic and individualized cancer model.
The iHuPDX technology provides a tumor model that more closely matches the patient's actual condition by collecting cancer tissue samples from the patient and transplanting them into an animal, such as a mouse, to form an individualized transplanted tumor. Key advantages of this technology include.
Individualized Disease Models: iHuPDX technology establishes highly individualized disease models based on individual patient's tumor cells, which helps to provide a more comprehensive understanding of the patient's tumor characteristics, and providing important support for precision medicine.
Drug response prediction: Due to the highly individualized nature of the model, iHuPDX technology can be used to test the response of different drugs to a specific patient's tumor, providing a powerful tool for the development of personalized treatment plans, which is expected to improve the success rate of treatment. for the development of personalized treatment plans, which is expected to improve the success rate of treatment.
New perspectives in cancer research: iHuPDX technology enables researchers to probe more deeply into the differences in tumor heterogeneity among different patients, helping to reveal the diversity of cancers and providing important information for the development of individualized treatment strategies. strategy development.
Founded by scientists from Novo Nordisk China R&D Center, SinoMediGuanco, and the Institute of Immunology at Shanghai Jiao Tong University, InnoModels Biotechnology (Beijing) Co., Ltd. is confident in the future of iHuPDX technology. With the deepening of biomedical research and continuous technological innovation, iHuPDX is expected to play a more important role in the field of personalized medicine. In the future, we can expect to see more research results and application scenarios related to iHuPDX technology.
- Tel 15010000264
- E-mail limy@imodels.tech
- Tel 13810723384
- Top
InnoModels Biotechnology (Beijing) Co., Ltd.
TEL:15010000264 13810723384
Email:cndw@imodels.tec
Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing
Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company